semaglutide side effects in women Woman shares what happened after she stopped taking Ozempic, Mounjaro, Rybelsus & Wegovy

More About GLP-1 GLP-1 is a glucagon-like peptide-1 (GLP-1) receptor agonist

Weight Limit is a series that examines the rise of weight loss drugs like Wegovy and how they impact young people

The .25mg starting dose of semaglutide represents the lowest therapeutic threshold, designed to allow your body to adapt to GLP-1 receptor activation while minimizing initial side effects

FDA Approval Status Another key difference is regulatory approval

When Cook joined Noom in 2023, the company had already rolled out a program called Noom Med that offered branded GLP-1 drugs like Novo Nordisks Ozempic and Eli Lillys Mounjaro in combination with a tailored behavioral program that focused on eating enough protein and workout regimens